Vancomycin resistance in Enterococcus faecium strains Isolated at a University Hospital;Resistencia a vancomicina en cepas de Enterococcus faecium Aisladas en un Hospital Universitario

Kasmera

Volumn 39, Issue 1, 2011, Pages 7-17

  Perozo Mena, Armindo José ^a,b   Castellano González, Maribel Josefina ^a,b   Ginestre Pérez, Messaria María ^a,b   Rincón Villalobos, Gresleida Coromoto ^a,b  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Facultad de Medicina LUZ   (Venezuela)

Author keywords

Enterococcus faecium; Resistance; VanA; Vancomycin

Indexed keywords

EID: 84862897705     PISSN: 00755222     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology 2009 Jun 1; 155(6):1749-57.
2. Pompei R, Lampis G, Berlutti F, Thaller MC. Characterization of yellow-pigmented enterococci from severe human infections. J Clin Microbiol 1991 Dec; 29(12):2884-6.
3. Texeira L, Siqueira M, Facklam R. Enterococcus. In: Murray P, Baron E, Jorgensen J, Landry M, Pfaller M, editors. Manual of Clinical Microbiology. 9th ed. Washington DC: ASM Press; 2007. p. 430-42.
4. Endtz HP, van den BN, van BA, Goessens WH, Kreft D, Stroebel AB, et al. Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol 1998 Feb; 36(2):592-4.
5. Amyes SGB. Enterococci and streptococci. International Journal of Antimicrobial Agents 2007 May; 29 (Supplement 3): S43-S52.
6. Hancock L, Gilmore M. Pathogenicity of Enterococci. In: Fischetti V, Novick R, Ferretti J, Portnoy D, Rood J, editors. Gram-Positive Pathogens. Washington DB USA: ASM Press; 2000. p. 251-8.
7. Koneman E, Allen S, Janda W, Schreckenberger P, Winn W. Diagnóstico Microbiológico. Quinta Edición ed. Editorial Médica Panamericana; 1999.
8. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990 Jan 1; 3(1): 46-65.
9. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001 Dec; 29(6):404-21.
10. Mendez-Alvarez S, Perez-Hernandez X, Claverie-Martin F. Glycopeptide resistance in enterococci. Int Microbiol 2000 Jun; 3(2):71-80.
11. Pineda M, Bonilla X, Perozo-Mena A. Boletín Sobre Etiología y Resistencia Bacteriana. 2007. Centro de Referencia Bacteriológica SAHUM.
12. Programa Venezolano de Vigilancia de la Resistencia Bacteriana a los Antimicrobianos. Programa Venezolano de Vigilancia de la Resistencia Bacteriana a los Antimicrobianos. 2009. 10-9-2009.
13. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001 May 15;32 Suppl 2: S133-S145.
14. SENTRY Antimicrobial Surveillance Program. Gram Positive Pathogens Susceptibility Report. 2009. 10-8-2009.
15. Carmona O, Guzmán M, Martin G. Resistencia Bacteriana a los Antimicrobianos en Venezuela. Sociedad Venezolana de Microbiología; 2002.
16. Contreras R, Texeira G, Inciarte L, Sanz L, Carmona O, Grupo Venezolano de Vigilancia de la Resistencia Bacteriana. Resistencia de Enterococcus a los antimicrobianos en Venezuela. Boletín de la Sociedad Venezolana de Microbiología 1995; 15(1):11-5.
17. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993 Jul 10; 342(8863): 76-9.
18. Manso E, De SG, Biavasco F, Varaldo PE, Sambo G, Maffei C. Vancomycin-resistant enterococci. Lancet 1993 Sep 4; 342(8871): 616-7.
19. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-Resistant Enterococci. Clin Microbiol Rev 2000 Oct 1; 13(4):686-707.
20. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966 Apr; 45(4):493-6.
21. Clinical and Laboratory Standards Institute. Performance standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement. Clinical and Laboratory Standards Institute, editor. M100-S20[30]. 2010. Clinical and Laboratory Standards Institute.
22. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Test; Approved Standard Tenth Edition. Clinical and Laboratory Standards Institute, editor. M02-A10[29]. 2009. Clinical And Laboratory Standard Institute.
23. Depardieu F, Perichon B, Courvalin P. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J Clin Microbiol 2004 Dec; 42(12):5857-60.
24. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995 Jan; 33(1):24-7.
25. Biavasco F, Foglia G, Paoletti C, Zandri G, Magi G, Guaglianone E, et al. VanA-Type Enterococci from Humans, Animals, and Food: Species Distribution, Population Structure, Tn1546 Typing and Location, and Virulence Determinants. Appl Environ Microbiol 2007 May 15; 73(10):3307-19.
26. Khan MA, van der Wal M, Farrell DJ, Cossins L, van Belkum A, Alaidan A, et al. Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types. J Antimicrob Chemother 2008 Aug 1; 62(2):279-83.
27. Paoletti C, Foglia G, Princivalli MS, Magi G, Guaglianone E, Donelli G, et al. Co-transfer of vanA and aggregation substance genes from Enterococcus faecalis isolates in intraand interspecies matings. J Antimicrob Chemother 2007 May 1; 59(5):1005-9.
28. Song JH, Ko KS, Suh JY, Oh WS, Kang CI, Chung DR, et al. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype. J Antimicrob Chemother 2008 Apr 1; 61(4):838-44.
29. Mundy LM, Sahm DF, Gilmore M. Relationships between Enterococcal Virulence and Antimicrobial Resistance. Clin Microbiol Rev 2000 Oct 1; 13(4):513-22.
30. Abele-Horn M, Vogel U, Klare I, Konstabel C, Trabold R, Kurihara R, et al. Molecular Epidemiology of Hospital-Acquired Vancomycin-Resistant Enterococci. J Clin Microbiol 2006 Nov 1; 44(11):4009-13.
31. Ergani-Ozcan A, Naas T, Baysan BO, Ogunc D, Inan D, Colak D, et al. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital. J Antimicrob Chemother 2008 May 1; 61(5):1033-9.
32. Fica A, Jemenao MI, Bilbao P, Ruiz G, Sakurada A, Perez de AE, et al. [Emergency of vancomycin-resistant Enterococcus infections in a teaching hospital in Chile]. Rev Chilena Infectol 2007 Dec; 24(6):462-71.
33. Ofner-Agostini M, Johnston BL, Simor AE, Embil J, Matlow A, Mulvey M, et al. Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005. Infect Control Hosp Epidemiol 2008 Mar; 29(3):271-4.
34. Yildirim M, Sencan I, Ozdemir D, Oksuz S, Yilmaz Z, Sahin I. [Vancomycin and highlevel aminoglycoside resistant Enterococcus carriage and the risk factors related to resistance in hospitalized patients]. Mikrobiyol Bul 2007 Apr; 41(2):271-7.
35. Yeh KM, Siu LK, Chang JC, Chang FY. Vancomycin-resistant enterococcus (VRE) carriage and infection in intensive care units. Microb Drug Resist 2004;10(2):177-83.
36. Pearce CL, Evans MK, Peters SM, Cole MF. Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital. Am J Infect Control 1998 Dec; 26(6):563-8.
37. Thal L, Donabedian S, Robinson-Dunn B, Chow JW, Dembry L, Clewell DB, et al. Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period. J Clin Microbiol 1998 Nov; 36(11): 3303-8.
38. Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 2001 Apr; 22(4):217-9.
39. Aarestrup FM, Agerso Y, Gerner-Smidt P, Madsen M, Jensen LB. Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagn Microbiol Infect Dis 2000 Jun; 37(2):127-37.
40. Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K. Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). J Clin Microbiol 1997 Dec 1; 35(12):3166-70.
41. Coombs GW, Kay ID, Steven RA, Pearman JW, Bertolatti D, Grubb WB. Should genotypic testing be done on all phenotypically vancomycin- resistant enterococci detected in hospitals? J Clin Microbiol 1999 Apr; 37(4):1229-30.
42. Dutka-Malen S, Blaimont B, Wauters G, Courvalin P. Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother 1994 Jul; 38(7):1675-7.
43. Lu JJ, Wu JC, Chiueh TS, Perng CL, Chi WM, Lee WH. Characterization of a highly glycopeptide-resistant Enterococcus gallinarum isolate. J Formos Med Assoc 2000 Apr; 99(4):305-10.
44. Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 2000 Nov; 19(11):816-22.
45. Jensen LB, Ahrens P, Dons L, Jones RN, Hammerum AM, Aarestrup FM. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol 1998 Feb; 36(2):437-42.
46. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycinresistant Enterococcus faecium. J Antimicrob Chemother 1994 Oct; 34(4):515-28.
47. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycinresistant enterococcal infection in man. JAntimicrob Chemother 1994 Oct; 34(4):507-14.
48. Stobberingh E, van den BA, London N, Driessen C, Top J, Willems R. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother 1999 Sep; 43(9):2215-21.
49. Aarestrup FM. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist 1995; 1(3):255-7.
50. French GL. Enterococci and vancomycin resistance. Clin Infect Dis 1998 Aug;27 Suppl 1: S75-S83.
51. Bostic GD, Perri MB, Thal LA, Zervos MJ. Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci. Diagn Microbiol Infect Dis 1998 Feb; 30(2):109-12.
52. Seid J, Asrat D. Occurrence of extended spectrum [beta]-lactamase enzymes in clinical isolates of Klebsiella species from Harar region, eastern Ethiopia. Acta Tropica 2005 Aug; 95(2):143-8.
53. Dutka-Malen S, Leclercq R, Coutant V, Duval J, Courvalin P. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob Agents Chemother 1990 Oct; 34(10):1875-9.